Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects.

Johnson BA, O'Malley SS, Ciraulo DA, Roache JD, Chambers RA, Sarid-Segal O, Couper D.

J Clin Psychopharmacol. 2003 Jun;23(3):281-93.

PMID:
12826990
2.

Rationale for combining acamprosate and naltrexone for treating alcohol dependence.

Mason BJ.

J Stud Alcohol Suppl. 2005 Jul;(15):148-56; discussion 140. Review.

PMID:
16223066
3.

A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone.

Mason BJ, Goodman AM, Dixon RM, Hameed MH, Hulot T, Wesnes K, Hunter JA, Boyeson MG.

Neuropsychopharmacology. 2002 Oct;27(4):596-606.

4.
5.

Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study.

Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach R, Kämpf P, Stracke R, Baehr M, Naber D, Wiedemann K.

Arch Gen Psychiatry. 2003 Jan;60(1):92-9.

PMID:
12511176
6.

Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?

Richardson K, Baillie A, Reid S, Morley K, Teesson M, Sannibale C, Weltman M, Haber P.

Addiction. 2008 Jun;103(6):953-9. doi: 10.1111/j.1360-0443.2008.02215.x.

PMID:
18482418
7.

Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.

Rubio G, Jiménez-Arriero MA, Ponce G, Palomo T.

Alcohol Alcohol. 2001 Sep-Oct;36(5):419-25. Erratum in: Alcohol Alcohol 2002 Jan-Feb;37(1):105.

PMID:
11524308
8.
9.

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.

Bouza C, Angeles M, Muñoz A, Amate JM.

Addiction. 2004 Jul;99(7):811-28. Review. Erratum in: Addiction. 2005 Apr;100(4):573. Magro, Angeles [corrected to Angeles, Magro].

PMID:
15200577
10.

Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.

Morley KC, Teesson M, Reid SC, Sannibale C, Thomson C, Phung N, Weltman M, Bell JR, Richardson K, Haber PS.

Addiction. 2006 Oct;101(10):1451-62.

PMID:
16968347
11.

Effect of the combination of naltrexone and acamprosate on alcohol intake in mice.

Kim SG, Han BD, Park JM, Kim MJ, Stromberg MF.

Psychiatry Clin Neurosci. 2004 Feb;58(1):30-6.

12.

Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.

Donovan DM, Anton RF, Miller WR, Longabaugh R, Hosking JD, Youngblood M; COMBINE Study Research Group.

J Stud Alcohol Drugs. 2008 Jan;69(1):5-13.

PMID:
18080059
13.

Combined therapy: what does acamprosate and naltrexone combination tell us?

Kiefer F, Wiedemann K.

Alcohol Alcohol. 2004 Nov-Dec;39(6):542-7. Epub 2004 Sep 29.

PMID:
15456690
14.

Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.

Namkoong K, Lee BO, Lee PG, Choi MJ, Lee E.

Alcohol Alcohol. 2003 Mar-Apr;38(2):135-41.

PMID:
12634260
15.

Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study.

Mann K, Kiefer F, Smolka M, Gann H, Wellek S, Heinz A; PREDICT Study Research Team.

Alcohol Clin Exp Res. 2009 Apr;33(4):674-83. doi: 10.1111/j.1530-0277.2008.00884.x. Epub 2009 Jan 20.

PMID:
19170666
16.

Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment.

Mason BJ.

Eur Neuropsychopharmacol. 2003 Dec;13(6):469-75. Review.

PMID:
14636963
17.

Pharmacological relapse prevention of alcoholism: clinical predictors of outcome.

Kiefer F, Helwig H, Tarnaske T, Otte C, Jahn H, Wiedemann K.

Eur Addict Res. 2005;11(2):83-91.

PMID:
15785069
18.

Acamprosate for the treatment of alcohol dependence.

Boothby LA, Doering PL.

Clin Ther. 2005 Jun;27(6):695-714. Review.

PMID:
16117977
19.

Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol.

Paille FM, Guelfi JD, Perkins AC, Royer RJ, Steru L, Parot P.

Alcohol Alcohol. 1995 Mar;30(2):239-47.

PMID:
7662044
20.

A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence.

Laaksonen E, Koski-Jännes A, Salaspuro M, Ahtinen H, Alho H.

Alcohol Alcohol. 2008 Jan-Feb;43(1):53-61. Epub 2007 Oct 27.

PMID:
17965444

Supplemental Content

Support Center